Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Hammadieh et al intended their letter to alert doctors to the
fact that patients who have had successful bone marrow transplantation
have peripheral blood cells originating from the donated bone marrow
and that results of cytogenetic studies of these blood cells will
relate to the donor.1
Unfortunately, only one of the two cases in the letter (case 1) was a
cytogenetic case, involving a bone marrow transplant from a donor of
the opposite sex. Hammadieh et al rightly pointed out that in such
cases a male will have a female karyotype. However, the other case
(case 2) was not a cytogenetic case. DF508 mutations in cystic fibrosis
are detected by molecular genetic techniques in a DNA laboratory. DNA
extracted from a blood sample before bone marrow transplantation can be
used subsequently only for DNA and molecular studies. These
distinctions are important to prevent the collection of an incorrect